Serotiny
San Francisco, US · Founded 2014 · 1 known investors
Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer. The San Francisco-based company works upstream in the cell and gene therapy discovery process and was acquired by Johnson & Johnson.
Founders & leadership
Serotiny was founded in 2014 by Justin Farlow and Colin Farlow.
Investors · 1
Reported raises · per SEC filings
Form D private placements$7M disclosed across 2 rounds · 2018–2023
▶$4MraisedMar 2023 · 2 investors · BiotechnologyRule 506(b)
- Justin FarlowExecutive Officer, Director
- Colin FarlowExecutive Officer, Director
- Eric MoessingerDirector
- Offering amount
- $4.5M
- Amount sold
- $4M
- Minimum investment
- $1
- First sale
- Mar 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$3MraisedJul 2018 · 8 investors · BiotechnologyRule 506(c)
- Eric MoessingerDirector
- Justin FarlowExecutive Officer, Director
- Colin FarlowExecutive Officer, Director
- Offering amount
- $3M
- Amount sold
- $3M
- Minimum investment
- $1K
- Proceeds to insiders
- $30K
- First sale
- Jun 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2016 | $150K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Serotiny do?
- Serotiny designs cell therapies using custom software and lab techniques that allow it to design and test up to 10,000 therapeutic genes at once, aiming to speed up the discovery of treatments for cancers such as multiple myeloma, prostate cancer and lung cancer. The San Francisco-based company works upstream in the cell and gene therapy discovery process and was acquired by Johnson & Johnson.
- Who founded Serotiny?
- Serotiny was founded by Justin Farlow, Colin Farlow in 2014.
- Who are Serotiny's investors?
- Serotiny's investors include +ND Capital.
- How much funding has Serotiny raised?
- Serotiny has disclosed $7M raised across 2 rounds.
- Where is Serotiny headquartered?
- Serotiny is headquartered in San Francisco, US.